These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis. Shah NJ, Shah UN. Indian J Ophthalmol; 2011 Mar; 59(4):318-9. PubMed ID: 21666322 [Abstract] [Full Text] [Related]
11. Intravitreal bevacizumab in the treatment of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension. Lee IJ, Maccheron LJ, Kwan AS. J Neuroophthalmol; 2013 Jun; 33(2):155-7. PubMed ID: 23235432 [Abstract] [Full Text] [Related]
12. Ranibizumab for choroidal neovascular membrane in a rare case of Bietti's crystalline dystrophy: a case report. Nachiappan K, Krishnan T, Madhavan J. Indian J Ophthalmol; 2012 Jun; 60(3):207-9. PubMed ID: 22569382 [Abstract] [Full Text] [Related]
13. Intravitreal bevacizumab treatment of bilateral peripapillary choroidal neovascularization from optic nerve head drusen. Knape RM, Zavaleta EM, Clark CL, Khuddus N, Peden MC. J AAPOS; 2011 Feb; 15(1):87-90. PubMed ID: 21397813 [Abstract] [Full Text] [Related]